Eric Rowinsky
Chairman bei PURPLE BIOTECH LTD
Vermögen: 5 Mio $ am 31.03.2024
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michel Vounatsos | M | 62 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 8 Jahre |
Lindsay Rosenwald | M | 68 | 15 Jahre | |
Stelios Papadopoulos | M | 75 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 16 Jahre |
Robert Gagnon | M | 49 | 14 Jahre | |
Krishnan Nandabalan | M | 61 |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | 19 Jahre |
Dan Paterson | M | 63 | 13 Jahre | |
Ian Ying Woo | M | 51 | 6 Jahre | |
Michael Kauffman | M | 60 |
The Johns Hopkins University School of Medicine
| 20 Jahre |
Richard Mulligan | M | 69 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 18 Jahre |
Alexander Denner | M | 54 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 18 Jahre |
Kristiina Vuori | M | 56 |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | 29 Jahre |
Lynn Schenk | F | 79 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos.
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | 29 Jahre |
John Johnson | M | 66 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 6 Jahre |
Gil Efron | M | 57 | 6 Jahre | |
Daniel Calkins | M | 37 | 6 Jahre | |
Caroline Dorsa | F | 64 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 14 Jahre |
Andrei V. Gudkov | M | 66 |
Oncotartis, Inc.
Oncotartis, Inc. Pharmaceuticals: MajorHealth Technology Oncotartis, Inc. operates as a biotechnology company. The company was founded by Andrei Gudkov, Alexander Polinsky and Olga Chernova in 2011 and is headquartered in Buffalo, NY. | 13 Jahre |
Jean Mariani | M | 74 | 5 Jahre | |
Simcha Rock | M | 73 | 11 Jahre | |
Brian Stuglik | M | 64 | 7 Jahre | |
Vimal Mehta | M | 63 |
BioXcel Corp.
BioXcel Corp. Data Processing ServicesTechnology Services BioXcel Corp. is a biopharmaceutical company based in Branford, CT that utilizes advanced technologies such as AI to develop transformative medicines at unprecedented speed in multiple therapeutic areas with high unmet needs. BioXcel's AI-enabled platform, EvolverAI, helps reduce development costs and accelerates the drug development timelines for a technologically-enabled, fast and efficient drug discovery process. The private company's family of companies includes BioXcel Therapeutics, Inc., which is a biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing AI and its approaches. BioXcel is deeply involved in creating breakthroughs in various categories of diseases. The company was founded by Vimal D. Mehta and Krishnan Nandabalan, with Vimal D. Mehta serving as the CEO since incorporation. | 19 Jahre |
Christopher Viehbacher | M | 64 | 2 Jahre | |
Jean-Francois H. Geschwind | M | - |
Cage Pharma, Inc.
Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | 16 Jahre |
Xu Xin Liu | F | 40 | 3 Jahre | |
Stephen Sherwin | M | 75 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 14 Jahre |
Nancy L. Leaming | F | 76 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 16 Jahre |
Brian Posner | M | 62 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 16 Jahre |
Robert W. Pangia | M | 72 |
Biogen GmbH
Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The private company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | 27 Jahre |
Xiao Qin Lu | M | 49 | 8 Jahre | |
Lior Fhima | M | - | 2 Jahre | |
Ori Hershkovitz | M | 49 | 3 Jahre | |
Olga Chernova | M | - |
Oncotartis, Inc.
Oncotartis, Inc. Pharmaceuticals: MajorHealth Technology Oncotartis, Inc. operates as a biotechnology company. The company was founded by Andrei Gudkov, Alexander Polinsky and Olga Chernova in 2011 and is headquartered in Buffalo, NY. | 13 Jahre |
Matthew Calistri | M | - |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The private company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | - |
Yong Qing Luo | M | 54 | 2 Jahre | |
Hoi Yam Chui | F | 57 | 1 Jahre | |
Saeed Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 14 Jahre |
Michael Hencke | M | - | 12 Jahre | |
David Jin | M | 34 | - | |
Michelle Robertson | F | 57 | 3 Jahre | |
Samuel Berry | M | - | 8 Jahre | |
Shi Dong Jiang | M | 57 | 4 Jahre | |
Susan Langer | F | - | 1 Jahre | |
Jesus B. Mantas | M | 55 | 5 Jahre | |
Kevin Lorenz | M | 59 | 5 Jahre | |
Isaac Israel | M | 44 | 12 Jahre | |
Anil Kapur | M | 54 | 2 Jahre | |
Monish Patolawala | M | 54 | - | |
Yi Fan Li | M | 55 | 4 Jahre | |
William Hawkins | M | 70 | 5 Jahre | |
J. Lobell | M | 61 | 18 Jahre | |
David Sidransky | M | 64 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.
The Johns Hopkins University School of Medicine
| 30 Jahre |
Jimmie Harvey | M | 72 | 16 Jahre | |
Malcolm Hoenlein | M | 80 | 10 Jahre | |
Susan Alexander | F | 67 | 21 Jahre | |
Cathy Carew | F | - | - | |
Michael Schickler | M | 55 | 4 Jahre | |
Dov Klein | M | 72 | 9 Jahre | |
Yael Margolin | M | 70 | 1 Jahre | |
Wendell C. Taylor | M | - | - | |
Maria Freire | M | 69 | 3 Jahre | |
Jason Rifkin | M | 46 |
Cage Pharma, Inc.
Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | 11 Jahre |
Paul Bunn | M | 79 | 3 Jahre | |
David Gionco | M | 63 | 10 Jahre | |
Michael Weiss | M | 58 | 11 Jahre | |
Ido Agmon | M | 46 | 8 Jahre | |
Alexander Polinsky | M | 67 |
Oncotartis, Inc.
Oncotartis, Inc. Pharmaceuticals: MajorHealth Technology Oncotartis, Inc. operates as a biotechnology company. The company was founded by Andrei Gudkov, Alexander Polinsky and Olga Chernova in 2011 and is headquartered in Buffalo, NY. | 13 Jahre |
Hagop Youssoufian | M | 67 | 7 Jahre | |
Geoffrey L. Berman | M | - | 8 Jahre | |
Priya Singhal | M | 56 | 3 Jahre | |
Suzana Nahum Zilberberg | F | 53 | 3 Jahre | |
Kenneth Hoberman | M | 59 | 11 Jahre | |
Nicole Murphy | F | - | 9 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jed Andrew Latkin | M | 50 | 5 Jahre | |
Andrew Hirsch | M | 53 | 14 Jahre | |
Mike M. Goldberg | M | 65 | 5 Jahre | |
Robert M. Forrester | M | 60 | 8 Jahre | |
Joseph Chiapponi | M | 55 | 6 Jahre | |
Robyn Hunter | F | 62 | 11 Jahre | |
Christopher M. Lindblom | M | 52 | 2 Jahre | |
Gina Consylman | F | 52 | 7 Jahre | |
Daniel Lynch | M | 65 |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | 9 Jahre |
Michael Rice | M | 59 | 5 Jahre | |
John Paul Waymack | M | 71 | 52 Jahre | |
Michael Ehlers | M | - |
The Johns Hopkins University School of Medicine
| 7 Jahre |
Jean-Christophe Montigny | M | - | 10 Jahre | |
Jeffrey Hrkach | M | 58 | 8 Jahre | |
Gordon A. Troup | M | 70 | 8 Jahre | |
Harlan Weisman | M | 71 | 1 Jahre | |
Shahram Seyedin-Noor | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 7 Jahre |
Glenn L. Cooper | M | 71 | 4 Jahre | |
James Mullen | M | 65 | 21 Jahre | |
William Young | M | 79 | 11 Jahre | |
Ricardo J. Gonzalez | M | 53 | 2 Jahre | |
Noah Beerman | M | 62 | 2 Jahre | |
Mark Pykett | M | 60 | 4 Jahre | |
Anton G. Gueth | M | 67 | 1 Jahre | |
Brent L. Larson | M | 61 | 20 Jahre | |
Bobby Sandage | M | 70 | 2 Jahre | |
Masoud Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 13 Jahre |
Brian Sullivan | M | - | 9 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 82 | 82,00% |
Israel | 11 | 11,00% |
Deutschland | 10 | 10,00% |
Cayman Islands | 6 | 6,00% |
Frankreich | 2 | 2,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Eric Rowinsky
- Persönliches Netzwerk